ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION

Despite advances in the understanding of glioblastoma multiforme (GBM) molecular biology, genomics, and tumor microenvironment, prognosis for patients diagnosed with this disease remains dismal with standard therapies. We and others have shown utility in dendritic cell (DC) vaccination as an active...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Antonios, Joseph, Everson, Richard, Soto, Horacio, Khattab, Sara, Bethel, Jacob, Sun, Matthew, Mochizuki, Aaron, Lee, Alexander, Odesa, Sylvia, Billingslea-Yoon, Emma, Moughon, Diana, Wang, Anthony, Cloughesy, Tim, Prins, Robert, Liau, Linda
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216157/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars